There was some evidence that cannabinoids can reduce symptoms of cannabis use disorder, insomnia, tic or Tourette's syndrome, and autism spectrum disorder, but the quality of this evidence was ...
MedPage Today on MSN
Cannabinoids for mental, substance use disorders 'rarely justified,' study suggests
Cannabis compounds may reduce symptoms for some disorders, but evidence quality is low ...
(RTTNews) - LB Pharmaceuticals Inc. (LBRX), a clinical-stage biopharmaceutical company, announced the initiation of a Phase 2 trial of investigational drug LB-102 in bipolar depression, dubbed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results